China Legalizes the World's First Gene Therapy Medication

  • Thread starter Thread starter Carlos Hernandez
  • Start date Start date
  • Tags Tags
    China Gene Therapy
Click For Summary
SUMMARY

The world's first commercially available gene therapy medication has been approved for treating head and neck squamous cell carcinoma in China. Shenzhen SiBiono Gene Technologies received the approval from regulatory authorities, with the medication expected to enter a market projected to reach $100 million in 2004. The therapy utilizes adenoviruses as vectors, which are temporary and do not result in permanent genetic changes, serving as a complementary treatment alongside conventional therapies.

PREREQUISITES
  • Understanding of gene therapy principles
  • Familiarity with adenoviral vectors
  • Knowledge of head and neck squamous cell carcinoma
  • Awareness of regulatory processes for medical approvals in China
NEXT STEPS
  • Research the mechanisms of adenoviral gene therapy
  • Explore the regulatory landscape for gene therapy in China
  • Investigate the clinical trials related to head and neck cancer treatments
  • Learn about the economic implications of emerging gene therapies
USEFUL FOR

Oncologists, genetic researchers, pharmaceutical professionals, and anyone interested in the advancements of gene therapy and its market potential.

Carlos Hernandez
Messages
84
Reaction score
0
Cancer Gene Therapy World's First to Market
Gabe Romain
Betterhumans Staff
Thursday, November 20, 2003, 4:27:07 PM CT

Thursday, November 20, 2003, 4:27:07 PM CT

The world's first commercially available gene therapy medication will soon be treating head and neck cancer in China.

Edison, New Jersey-based research equipment manufacturer New Brunswick Scientific announced that approval to produce the medication for treating head and neck squamous cell carcinoma has been granted to China's Shenzhen SiBiono Gene Technologies.

Complete text at http://www.betterhumans.com/Errors/index.aspx?aspxerrorpath=/Search_Engine_Links/2003/searchEngineLink.article.2003-11-20-5.aspx
 
Last edited by a moderator:
Biology news on Phys.org
Well, the correct thing to say is: "It is the first gene therapy drug in the world approved for sale in what is predicted to be a $100 million market in 2004."

The first and successfull gene therapy trial already took place on September 14 1990 on the disease ADA SCID.

I wonder though, how and what are they doing? They are using adenoviruses as the vector, these are not permanent and will disappear from the bodies' cells. So this is not genetic engineering per se, for those who are wondering. It IS a helpfull measure to complement conventional treatment, I imagine..
 

Similar threads

Is a Genetic Mutation Creating a Real-Life Superman?
  • · Replies 1 ·
Replies
1
Views
12K